Mirum Pharmaceuticals, Inc. MIRM Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s accumulated depreciation?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accumulated depreciation of $67.44M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s accumulated depreciation changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accumulated depreciation increased by 57.8% year-over-year, from $42.75M to $67.44M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accumulated depreciation?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s accumulated depreciation has grown at a 110.7% compound annual growth rate (CAGR), from $13.67M to $60.67M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.